The routine commissioning of loteprednol is accepted in Devon for the treatment of steroid responsive inflammatory eye conditions in patients who have a known clinically significant rise in intraocular pressure with other steroid eye drops.
| Filename: | Loteprednol (Lotemax®) for the treatment of steroid responsive inflammatory eye conditions |
| Filetype: | |
| Filesize: | 50.77 KB |
| Date uploaded: | 24th January 2020 |
| Date updated: | 8th December 2022 |
